User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

All Publications

Displaying 10 results.
    • Journal article
    Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
    Perrot, Aurore Lauwers-Cances, Valerie Corre, Jill Robillard, Nelly Hulin, Cyrille Chretien, Marie-Lorraine Dejoie, Thomas Maheo, Sabrina Stoppa, Anne-Marie Pegourie, Brigitte Karlin, Lionel Garderet, Laurent Arnulf, Bertrand Doyen, Chantal[UCL] Meuleman, Nathalie Royer, Bruno Eveillard, Jean-Richard Benboubker, Lotfi Dib, Mamoun Decaux, Olivier Jaccard, Arnaud Belhadj, Karim Brechignac, Sabine Kolb, Brigitte Fohrer, Cecile Mohty, Mohamad Macro, Margaret Richardson, Paul G Carlton, Victoria Moorhead, Martin Willis, Tom Faham, Malek Anderson, Kenneth C Harousseau, Jean-Luc Leleu, Xavier Facon, Thierry Moreau, Philippe Attal, Michel Avet-Loiseau, Hervé Munshi, Nikhil (2018) Blood — Vol. 132, no. 23, p. 2456-2464 (2018)
    • Journal article
    Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience.
    Caulier, Alexis Roussel, Murielle Morel, Pierre Lombion, Naelle Branco, Benoît Galtier, Jean Hulin, Cyrille Perrot, Aurore Richez, Valentine Michaud, Anne-Victoire Touzeau, Cyrille Doyen, Chantal[UCL] Mariette, Clara Caillot, Denis Harel, Stéphanie Lenain, Pascal Ivanoff, Sarah Fontan, Jean Stoppa, Anne-Marie Manier, Salomon Garderet, Laurent Leleu, Xavier Marolleau, Jean-Pierre Arnulf, Bertrand Avet-Loiseau, Hervé Royer, Bruno (2021) Blood — Vol. 138, no. 25, p. 2686-2695 (2021)
    • Speech
    Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine (FIT Cyclophosphamide (C) and MabCampath (Cam) (FCCam) in Previously Untreated Patients (pts) with Advanced B-Chronic Lymphocytic Leukemia (B-CLL) : Experience On Safety and Efficacy within a Randomised Multicenter Phase III Trial of the french Cooperative Group On CIA, and WM (FCGCLL/MW) and the "Groupe Ouest-Est d'Etudes Des Leucemies Aigues Et Autres Maladies Du sang" (GOELAMS): CLL2007FMP (for fit medically patients)
    Lepretre, Stephane Van Den Neste, Eric[UCL] Aurran, Therese Mahe, Beatrice Cazin, Bruno Tournihlac, Olivier Maisonneuve, Herve Casasnovas, Olivier Delmer, Alain Leblond, Veronique Royer, Bruno Corront, Brigitte Chevret, Sylvie Delepine, Roselyne Vaudaux, Sandrine Bene, Marie-Christine Cymbalista, Florence Feugier, Pierre (2009) 51st Annual Meeting of the American-Society-of-Hematology — New Orleans (La)
    • Journal article
    Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial.
    Lepretre, Stephane Aurran, Therese Mahé, Beatrice Cazin, Bruno Tournilhac, Olivier Maisonneuve, Herve Casasnovas, Olivier Delmer, Alain Leblond, Veronique Royer, Bruno Corront, Bernadette Chevret, Sylvie Delépine, Roselyne Vaudaux, Sandrine Van Den Neste, Eric Béné, Marie Christine Letestu, Remi Cymbalista, Florence Feugier, Pierre (2012) Blood — Vol. 119, no.22, p. 5104-5110 (2012)
    • Journal article
    Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia.
    Feugier, Pierre Aurran, Thérèse Mahé, Béatrice Letestu, Remi Nguyen-Khac, Florence Cazin, Bruno Tournilhac, Olivier Maisonneuve, Hervé Casasnovas, Olivier Delmer, Alain Leblond, Véronique Royer, Bruno Corront, Bernadette Chevret, Sylvie Delépine, Roselyne Vaudaux, Sandrine Van Den Neste, Eric[UCL] Béné, Marie-Christine Cymbalista, Florence Ross-Weil, Damien Leprêtre, Stéphane (2018) Haematologica — Vol. 103, no.7, p. e304-e306 (2018)
    • Journal article
    Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.
    Pertesi, Maroulio Vallée, Maxime Wei, Xiaomu Revuelta, Maria V Galia, Perrine Demangel, Delphine Oliver, Javier Foll, Matthieu Chen, Siwei Perrial, Emeline Garderet, Laurent Corre, Jill Leleu, Xavier Boyle, Eileen M Decaux, Olivier Rodon, Philippe Kolb, Brigitte Slama, Borhane Mineur, Philippe Voog, Eric Le Bris, Catherine Fontan, Jean Maigre, Michel Beaumont, Marie Azais, Isabelle Sobol, Hagay Vignon, Marguerite Royer, Bruno Perrot, Aurore Fuzibet, Jean-Gabriel Dorvaux, Véronique Anglaret, Bruno Cony-Makhoul, Pascale Berthou, Christian Desquesnes, Florence[UCL] Pegourie, Brigitte Leyvraz, Serge Mosser, Laurent Frenkiel, Nicole Augeul-Meunier, Karine Leduc, Isabelle Leyronnas, Cécile Voillat, Laurent Casassus, Philippe Mathiot, Claire Cheron, Nathalie Paubelle, Etienne Moreau, Philippe Bignon, Yves-Jean Joly, Bertrand Bourquard, Pascal Caillot, Denis Naman, Hervé Rigaudeau, Sophie Marit, Gérald Macro, Margaret Lambrecht, Isabelle Cliquennois, Manuel Vincent, Laure Helias, Philippe Avet-Loiseau, Hervé Moreno, Victor Reis, Rui Manuel Varkonyi, Judit Kruszewski, Marcin Vangsted, Annette Juul Jurczyszyn, Artur Zaucha, Jan Maciej Sainz, Juan Krawczyk-Kulis, Malgorzata Wątek, Marzena Pelosini, Matteo Iskierka-Jażdżewska, Elzbieta Grząśko, Norbert Martinez-Lopez, Joaquin Jerez, Andrés Campa, Daniele Buda, Gabriele Lesueur, Fabienne Dudziński, Marek García-Sanz, Ramón Nagler, Arnon Rymko, Marcin Jamroziak, Krzysztof Butrym, Aleksandra Canzian, Federico Obazee, Ofure Nilsson, Björn Klein, Robert J Lipkin, Steven M McKay, James D Dumontet, Charles (2019) Leukemia — Vol. 33, no. 9, p. 2324-2330 (2019)
    • Journal article
    Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.
    Roussel, Murielle Lauwers-Cances, Valérie Macro, Margaret Leleu, Xavier Royer, Bruno Hulin, Cyrille Karlin, Lionel Perrot, Aurore Touzeau, Cyrille Chrétien, Marie-Lorraine Rigaudeau, Sophie Dib, Mamoun Nicolas-Virelizier, Emmanuelle Escoffre-Barbe, Martine Belhadj, Karim Mariette, Clara Stoppa, Anne-Marie Araujo, Carla Doyen, Chantal[UCL] Fontan, Jean Kolb, Brigitte Garderet, Laurent Brechignac, Sabine Malfuson, Jean-Valère Jaccard, Arnaud Lenain, Pascal Borel, Cécile Hebraud, Benjamin Benbrahim, Omar Dorvaux, Véronique Manier, Salomon Augeul-Meunier, Karine Vekemans, Marie-Christiane[UCL] Randriamalala, Edouard Chaoui, Driss Caers, Jo Chaleteix, Carine Benboubker, Lofti Vincent, Laure Glaisner, Sylvie Zunic, Patricia Slama, Borhane Eveillard, Jean-Richard Humbrecht-Kraut, Catherine Morel, Véronique Mineur, Philippe Eisenmann, Jean-Claude Demarquette, Hélène Richez, Valentine Vignon, Marguerite Caillot, Denis Facon, Thierry Moreau, Philippe Colin, Anne-Laurène Olivier, Pascale Wuilleme, Soraya Avet-Loiseau, Hervé Corre, Jill Attal, Michel (2022) Blood — Vol. 139, no. 18, p. 2747-2757 (2022)
    • Journal article
    Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myélome study.
    Dumontet, Charles Demangel, Delphine Galia, Perrine Karlin, Lionel Roche, Laurent Fauvernier, Mathieu Golfier, Camille Laude, Marie-Charlotte Leleu, Xavier Rodon, Philippe Roussel, Murielle Azaïs, Isabelle Doyen, Chantal[UCL] Slama, Borhane Manier, Salomon Decaux, Olivier Pertesi, Maroulio Beaumont, Marie Caillot, Denis Boyle, Eileen M Cliquennois, Manuel Cony-Makhoul, Pascale Doncker, Anne-Violaine Dorvaux, Véronique Petillon, Marie Odile Fontan, Jean Hivert, Bénédicte Leduc, Isabelle Leyronnas, Cécile Macro, Margaret Maigre, Michel Mariette, Clara Mineur, Philippe Rigaudeau, Sophie Royer, Bruno Vincent, Laure Mckay, James Perrial, Emeline Garderet, Laurent (2023) American journal of hematology — Vol. 98, no. 2, p. 264-271 (2023)
    • Journal article
    Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
    Hulin, Cyrille Belch, Andrew Shustik, Chaim Petrucci, Maria Teresa Dührsen, Ulrich Lu, Jin Song, Kevin Rodon, Philippe Pégourié, Brigitte Garderet, Laurent Hunter, Hannah Azais, Isabelle Eek, Richard Gisslinger, Heinz Macro, Margaret Dakhil, Shaker Goncalves, Cristina LeBlanc, Richard Romeril, Ken Royer, Bruno Doyen, Chantal[UCL] Leleu, Xavier Offner, Fritz Leupin, Nicolas Houck, Vanessa Chen, Guang Ervin-Haynes, Annette Dimopoulos, Meletios A Facon, Thierry (2016) Journal of Clinical Oncology — Vol. 34, no. 30, p. 3609-3617 (2016)
    • Journal article
    Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.
    Boyle, Eileen M Leleu, Xavier Petillon, Marie-Odile Karlin, Lionel Doyen, Chantal[UCL] Demarquette, Hélène Royer, Bruno Macro, Margaret Moreau, Philippe Fostier, Karel Marie-Lorraine, Chretien Zarnitsky, Charles Perrot, Aurore Herbaux, Charles Poulain, Stephanie Manier, Salomon Beauvais, David Walker, Brian A Wardell, Christopher P Vincent, Laure Frenzel, Laurent Caillon, Hélène Susanna, Schraen Dejoie, Thomas Avet-Loiseau, Hervé Mohty, Mohamad Facon, Thierry IFM2014-04 investigators (2019) British journal of haematology — Vol. 187, no. 3, p. 319-327 (2019)